Affiliation: Singapore Immunology Network, A*STAR

Dr. Lim is a senior scientist who integrates structural biology and immunology to crack the cancer code. He is a trained structural biologist who pioneered two major histocompatibility complex class I inventions to identify antigen-specific T cells. He did his PhD at the National University of Singapore. He was awarded the A*STAR International Fellowship to hone his multidisciplinary skills at the University of Pennsylvania and the European Molecular Biology Laboratory, Grenoble.

He currently manages the service platform in mass cytometry and conducts R&D to identify new molecular targets for cancer. As a senior scientist, he has worked with several stakeholders in the field of cancer vaccines, nanotechnology, and immune profiling of various human diseases, including a first-authored cell atlas work in understanding COVID-19 severity.

He has published papers in top-tier journals. He is also a regular keynote speaker for Standard Biotools' mass cytometry in Asia Pacific.